CalciMedica, Inc.
CALC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $1 |
| Gross Profit | $0 | $0 | $0 | -$1 |
| % Margin | – | – | – | – |
| R&D Expenses | $14 | $16 | $8 | $19 |
| G&A Expenses | $10 | $22 | $6 | $17 |
| SG&A Expenses | $10 | $22 | $6 | $17 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | -$1 |
| Operating Expenses | $24 | $38 | $14 | $35 |
| Operating Income | -$24 | -$38 | -$14 | -$36 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $11 | $4 | $6 | $0 |
| Pre-Tax Income | -$14 | -$34 | -$8 | -$36 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$14 | -$34 | -$8 | -$36 |
| % Margin | – | – | – | – |
| EPS | -1.22 | -7.65 | -23.2 | -23.66 |
| % Growth | 84.1% | 67% | 1.9% | – |
| EPS Diluted | -1.22 | -7.65 | -23.2 | -23.66 |
| Weighted Avg Shares Out | 11 | 4 | 2 | 2 |
| Weighted Avg Shares Out Dil | 11 | 4 | 2 | 2 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $1 |
| EBITDA | -$24 | -$38 | -$8 | -$35 |
| % Margin | – | – | – | – |